Esther Tijchon

580 citations

15 papers · 339 indexed · h-index 9

Co-authors: Blanca Scheijen Frank N. van Leeuwen Peter M. Hoogerbrugge Liesbeth van Emst Rieka Stunnenberg Joan Conaway Hendrik G. Stunnenberg Ronald Conaway
Topics: Cancer-related gene regulation (9 papers)Acute Myeloid Leukemia Research (5 papers)Peptidase Inhibition and Analysis (4 papers)
Cited by: Hematology Molecular Biology Public Health, Environmental and Occupational Health
Journals: The EMBO Journal Blood PLoS ONE
Partner nations: Netherlands United States Italy

In The Last Decade

Esther Tijchon

15 papers receiving 337 citations

Peers

Countries citing papers authored by Esther Tijchon

Since Specialization

Citations

This map shows the geographic impact of Esther Tijchon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Tijchon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Tijchon more than expected).

Fields of papers citing papers by Esther Tijchon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Tijchon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Tijchon. The network helps show where Esther Tijchon may publish in the future.

Co-authorship network of co-authors of Esther Tijchon

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Tijchon. A scholar is included among the top collaborators of Esther Tijchon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Tijchon. Esther Tijchon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation 2023 ·Cells ·(unknown),(unknown),(unknown),Esther Tijchon,(unknown),Saskia M. Bergevoet,Bert A. van der Reijden,Joost H.A. Martens	6
2	The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model 2019 ·PLoS ONE ·Esther Tijchon,Guoqiang Yi,Amit Mandoli,(unknown),Francesco Ferrari,(unknown),(unknown),Bowon Kim,Eva M. Janssen‐Megens,Jan Jacob Schuringa,Joost H.A. Martens	14
3	CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1 2019 ·Blood Cancer Journal ·Guoqiang Yi,Amit Mandoli,(unknown),Esther Tijchon,(unknown),(unknown),Marten Hansen,Bowon Kim,Luan N. Nguyen,Pascal W.T.C. Jansen,Michiel Vermeulen,Bert van der Reijden,Emile van den Akker,Jonathan Bond,Joost H.A. Martens	7
4	RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs 2019 ·Blood Advances ·(unknown),Guoqiang Yi,Esther Tijchon,(unknown),Jan Jacob Schuringa,Joost H.A. Martens,Edo Vellenga	19
5	Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1 2018 ·Experimental Hematology ·Esther Tijchon,Liesbeth van Emst,Laurensia Yuniati,(unknown),(unknown),Laurens T. van der Meer,Owen Williams,Peter M. Hoogerbrugge,Blanca Scheijen,Frank N. van Leeuwen	4
6	Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients 2016 ·Haematologica ·Blanca Scheijen,Judith M. Boer,René Marke,Esther Tijchon,(unknown),Esmé Waanders,Liesbeth van Emst,Laurens T. van der Meer,Rob Pieters,Gabriele Escherich,Martin A. Horstmann,Edwin Sonneveld,Nicola C. Venn,Rosemary Sutton,Luciano Dalla‐Pozza,Roland P. Kuiper,Peter M. Hoogerbrugge,Monique L. den Boer,Frank N. van Leeuwen	40
7	Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton 2015 ·PLoS ONE ·Esther Tijchon,(unknown),(unknown),Felice Tirone,Peter M. Hoogerbrugge,Frank N. van Leeuwen,Blanca Scheijen	11
8	Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress 2015 ·Oncotarget ·Laurensia Yuniati,Laurens T. van der Meer,Esther Tijchon,(unknown),Liesbeth van Emst,(unknown),(unknown),(unknown),Geert Poelmans,Peter M. Hoogerbrugge,Jixiu Shan,Michael S. Kilberg,Blanca Scheijen,Frank N. van Leeuwen	26
9	Tumor Suppressors BTG1 and IKZF1 Cooperate during Mouse Leukemia Development and Impact Relapse Rate in Childhood Acute Lymphoblastic Leukemia 2015 ·Blood ·Blanca Scheijen,Esther Tijchon,(unknown),René Marke,Liesbeth van Emst,Laurens T. van der Meer,Roland P. Kuiper,Judith M. Boer,Rob Pieters,Peter M. Hoogerbrugge,Monique L. den Boer,Frank N. van Leeuwen	2
10	Loss Of Tumor Suppressor BTG1 Enhances ATF4 Function and Promotes Cell Survival 2013 ·Blood ·Laurens T. van der Meer,Laurensia Yuniati,Esther Tijchon,Liesbeth van Emst,(unknown),(unknown),Blanca Scheijen,Peter M. Hoogerbrugge,Frank N. van Leeuwen	1
11	B-lineage transcription factors and cooperating gene lesions required for leukemia development 2012 ·Leukemia ·Esther Tijchon,(unknown),Frank N. van Leeuwen,Blanca Scheijen	55
12	The Human EKC/KEOPS Complex Is Recruited to Cullin2 Ubiquitin Ligases by the Human Tumour Antigen PRAME 2012 ·PLoS ONE ·Adalberto Costessi,(unknown),Vikram Sharma,Rieka Stunnenberg,(unknown),Esther Tijchon,Joan Conaway,Ronald Conaway,Hendrik G. Stunnenberg	34
13	The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters 2011 ·The EMBO Journal ·Adalberto Costessi,(unknown),Esther Tijchon,Rieka Stunnenberg,(unknown),Pascal W.T.C. Jansen,(unknown),Skylar Martin‐Brown,Michael P. Washburn,Laurence Florens,Joan Conaway,Ronald Conaway,Hendrik G. Stunnenberg	57
14	BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia 2010 ·Blood ·Joost C. van Galen,Roland P. Kuiper,Liesbeth van Emst,(unknown),Esther Tijchon,Blanca Scheijen,Esmé Waanders,Simon V. van Reijmersdal,Christian Gilissen,Ad Geurts van Kessel,Peter M. Hoogerbrugge,Frank N. van Leeuwen	62
15	BTG1, a Gene Frequently Deleted in Pre-B ALL, Controls Glucocorticoid Receptor-Mediated Gene Expression. 2009 ·Blood ·Frank N. van Leeuwen,Joost C. van Galen,Roland P. Kuiper,Liesbeth van Emst,(unknown),Esther Tijchon,Blanca Scheijen,Esmé Waanders,Simon V. van Reijmersdal,(unknown),Ad Geurts van Kessel,Peter M. Hoogerbrugge	1

About Esther Tijchon

Esther Tijchon is a scholar working on Hematology, Molecular Biology and Oncology, having authored 15 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer-related gene regulation (9 papers), Acute Myeloid Leukemia Research (5 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (87 citations), Molecular Biology (218 citations) and Public Health, Environmental and Occupational Health (91 citations). Esther Tijchon has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include Blanca Scheijen, Frank N. van Leeuwen, Peter M. Hoogerbrugge, Liesbeth van Emst, Rieka Stunnenberg, Joan Conaway, Hendrik G. Stunnenberg, Ronald Conaway, Adalberto Costessi and Roland P. Kuiper. Their work appears in journals such as The EMBO Journal, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact